Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemo N0: Adjuvant Chemotherapy in Node-negative Breast Cancer
NCT01317108Phase 3Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jun 1993
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of cyclophosphamide, methotrexate, fluorouracil in breast cancer, sponsored by University Medical Center Hamburg-Eppendorf. Started Jun 1993; status: completed.
02
Drugs
cyclophosphamidemethotrexatefluorouracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01317108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01317108.